FH and hereditary clear cell renal cell carcinoma: Furuya et al. recently reported the clinicopathologial and molecular features of 13 Japanese patients with hereditary FH-deficient renal cell carcinomas: most tumors had type 2 papillary architecture or tubulocystic pattern or both; at immunohistochemical level, 10 tumors were positive for PD-L1; somatic mutation analysis showed loss of heterozygosity of FH in 10 tumors [70].